Hap Trading, LLC Mei Pharma, Inc. Call Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$0.54 - $2.74 $16,362 - $83,022	-30,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.33 - $3.37 $70,599 - $102,111	30,300 New	30,300 $5,000
Q3 2021 Nov 10, 2021	SELL	$2.52 - $2.99 $55,188 - $65,481	-21,900 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$2.6 - $3.65 $51,220 - $71,905	-19,700 Reduced 47.36%	21,900 $4,000
Q1 2021 May 14, 2021	BUY	$2.73 - $4.5 $52,416 - $86,400	19,200 Added 85.71%	41,600 $15,000
Q4 2020 Feb 16, 2021	SELL	$2.6 - $3.32 $2,080 - $2,656	-800 Reduced 3.45%	22,400 $3,000
Q3 2020 Nov 13, 2020	SELL	$2.46 - $4.27 $47,478 - $82,410	-19,300 Reduced 45.41%	23,200 $7,000
Q2 2020 Aug 10, 2020	BUY	$1.45 - $4.3 $37,120 - $110,080	25,600 Added 151.48%	42,500 $64,000
Q1 2020 May 08, 2020	BUY	$0.75 - $2.55 $12,675 - $43,095	16,900 New	16,900 $3,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $380M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.